Literature DB >> 11900873

Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies.

Henry T Lynch1, Jane F Lynch.   

Abstract

The translation of knowledge about hereditary breast cancer and its improved control, as well as prevention through prophylactic surgery, has been significantly accelerated through the veritable explosive discoveries in molecular genetics inclusive of BRCA1 and BRCA2 germline mutations. Needed however, among the physician community, medical geneticists, and genetic counselors, is a raised level of knowledge about hereditary breast cancer syndromes. Particular attention needs to be given to their extant genotypic and phenotypic heterogeneity, their natural history, and foremost, the requirement of a sufficiently detailed family history, with knowledge as to how to interpret its significance so that hereditary cancer syndrome can be diagnosed, should it, in fact, exist in the particular family. Collectively, surveillance and management programs can then be developed for the patient and his or her high-risk relatives. We believe very firmly that this knowledge needs to be extended to the individual patient(s), first- and second-degree relatives so that they can benefit from this knowledge.

Entities:  

Mesh:

Year:  2002        PMID: 11900873     DOI: 10.1016/s0300-9084(01)01363-3

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

Review 1.  [Carcinogenesis and hereditart colon cancers].

Authors:  F Kullmann
Journal:  Internist (Berl)       Date:  2003-03       Impact factor: 0.743

2.  Abnormal vascular network complexity: a new phenotypic marker in hereditary non-polyposis colorectal cancer syndrome.

Authors:  C De Felice; G Latini; G Bianciardi; S Parrini; G M Fadda; M Marini; R N Laurini; R J Kopotic
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

3.  ATM haplotypes and breast cancer risk in Jewish high-risk women.

Authors:  M Koren; G Kimmel; E Ben-Asher; I Gal; M Z Papa; J S Beckmann; D Lancet; R Shamir; E Friedman
Journal:  Br J Cancer       Date:  2006-05-22       Impact factor: 7.640

4.  Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy.

Authors:  Karolina Tecza; Jolanta Pamula-Pilat; Zofia Kolosza; Natalia Radlak; Ewa Grzybowska
Journal:  J Exp Clin Cancer Res       Date:  2015-01-16

Review 5.  Ovarian surface epithelium: family history and early events in ovarian cancer.

Authors:  Alice S T Wong; Nelly Auersperg
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.